AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC...
H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. has announced that Fujirebio Diagnos...
Japan-based Ono Pharmaceutical Co., and Vertex Pharmaceuticals Incorporated, in the US, have announced an exclusive coll...
Harbour BioMed, a China-based biopharmaceutical company, has announced a global strategic collaboration with Japan-headq...
Israel-based startup MedHub-AI, a global leader in artificial intelligence (AI)-powered cardiovascular diagnostics,...
Japan-based NEC Corporation, in collaboration with Chugai Pharmaceutical Co., has conducted an experiment usin...
UK-based Avata Biosciences Holdings has signed a co-development and licensing agreement with Oceanus Bio, Inc. for the e...
HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading...
Healthcare startup SDP Japan, Inc. has raised approximately JPY 4.5 billion (equivalent to $31 million) t...
Mitsubishi Research Institute, Inc. and Astellas Pharma Inc. have agreed on a Memorandum of Understanding (MoU) to...
Japan headquartered medtech firm Olympus Corp. has announced the full market release of its artificial intelligence (AI)...
Cardio Diagnostics Holdings Inc., a US-based artificial intelligence (AI)-powered precision cardiovascular medicine comp...
South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...
A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...
Australia-headquartered Telix Pharmaceuticals has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Te...
ThinkCyte, a Japan-based life science company pioneering advanced artificial intelligence (AI)-powered cell analysis and...
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...
